Foundations of Molecular Diagnostics

What is PCR (Polymerase Chain Reaction)?

PCR, or Polymerase Chain Reaction, is a method used to make many copies of a specific piece of DNA. DNA contains genetic information that guides how cells function, but in many samples the amount present is too small to analyze directly. PCR overcomes this by copying the target DNA repeatedly until there is enough to detect and study. The process follows a controlled pattern of heating and cooling. Heating separates the two strands of DNA. Cooling allows short DNA pieces, called primers, to attach to the region that needs to be copied. An enzyme then builds new DNA strands from these starting primers. Repeating this cycle produces millions of identical copies.

PCR is used across medicine and biology. It allows the detection of viruses and bacteria even when only a small amount is present. It helps identify genetic changes involved in disease and plays a role in areas such as forensic analysis. By increasing the amount of DNA available, PCR makes otherwise invisible information accessible.

What is Real‑Time PCR (qPCR)?

Real‑Time PCR, or qPCR, builds on the principles of PCR but adds the ability to measure the amount of DNA as it is being copied. This is useful when it is important to know not only whether a genetic target is present, but also in what quantity. The basic steps of warming, cooling and DNA copying remain the same. What sets qPCR apart is the use of fluorescent signals that increase as more DNA is produced. Instruments track this fluorescence during each cycle, allowing the amount of DNA to be monitored continuously.

This capability makes qPCR widely used in diagnostics and research. It can measure viral levels during infection, monitor gene activity and identify specific mutations in diseases such as cancer. Its sensitivity and ability to quantify genetic material make it a central tool in modern molecular testing.

What is DNA and Why Does It Matter in Disease?

DNA carries the instructions that guide the growth, repair and general function of every cell in the body. These instructions are written in a long sequence of chemical units that form genes. Genes provide the information needed to make proteins, which carry out essential roles such as building structures, sending signals and regulating processes. Although DNA is stable, changes can occur. These changes, known as mutations, can be harmless, but some alter how cells behave. If a mutation affects an important gene, it can contribute to disease. For example, cancer often develops when several mutations cause cells to grow uncontrollably.

Some changes in DNA are inherited from parents, while others arise during life from factors such as aging or environmental exposure. DNA activity can also be influenced without altering the sequence itself. This layer of control, called epigenetics, adjusts how strongly certain genes are used. Understanding DNA and the changes that affect it is a key part of modern medicine. Tools such as PCR, qPCR and sequencing allow clinicians to detect mutations, diagnose disease, choose appropriate treatments and monitor how conditions develop.

What Are Genetic Mutations?

Genetic mutation is a change in the DNA sequence. These changes may involve replacing, adding or removing small pieces of DNA. Many mutations have no effect, but others alter how cells function. Mutations can be inherited, meaning they are present from birth, or they can arise during life. Inherited mutations may contribute to conditions that run in families. Mutations acquired later in life can occur through natural copying errors or exposure to environmental factors.

Some mutations help explain why individuals respond differently to treatments or why certain diseases develop. Others can disrupt important cellular processes. When a mutation affects genes that control cell growth, for example, it may contribute to cancer. Identifying mutations helps clinicians choose the right diagnostic approach and the most suitable treatments. Modern molecular tools allow even very small changes in DNA to be detected and understood.

What Is Epigenetics and DNA Methylation?

Epigenetics refers to the mechanisms that control how actively different parts of the DNA are used. Although almost all cells contain the same DNA, they use different genes depending on their function. Epigenetic systems help maintain these patterns. One major epigenetic mechanism is DNA methylation. This involves adding methyl groups to specific areas of DNA. These additions do not change the DNA sequence, but they influence how easily a gene can be accessed. Heavily methylated genes are often less active.

DNA methylation supports normal development, cell identity and growth. However, when methylation patterns become abnormal, they can contribute to disease. In cancer, for example, genes that should be active may become silenced, or harmful genes may be activated. Because epigenetic changes can occur early in disease development, analyzing DNA methylation can provide valuable diagnostic information. It helps clarify what is happening inside cells and can support early detection.

Cancer Diagnostics Concepts

What Is a Biomarker?

A biomarker is a measurable indicator of a biological process or disease. It may be a molecule such as DNA or protein, or it may be a physical measurement such as blood pressure. Biomarkers help clinicians understand what is happening inside the body. In cancer, biomarkers can signal whether a tumor is present, how it behaves or how likely it is to respond to a specific treatment. They also help to assess whether a disease is returning or progressing. Biomarkers provide essential information for diagnosis, monitoring and treatment planning. Molecular biomarkers are very specific to a single target meaning that you will only get knowledge on the mutation of interest.

What Is Minimal Residual Disease (MRD)?

Minimal Residual Disease (MRD) refers to the small number of cancer cells that may remain after the completion of curative-intent treatment, despite the patient achieving clinical remission. These residual cells are typically undetectable using conventional imaging or standard laboratory methods but may eventually lead to disease relapse. Highly sensitive molecular techniques, such as PCR-based assays, can identify trace amounts of cancer-derived DNA in blood or bone marrow, enabling the detection of MRD at levels far below the threshold of conventional diagnostics. As a result, MRD assessment is primarily used as a tool for relapse monitoring and risk stratification after treatment, helping clinicians evaluate the likelihood of disease recurrence and determine whether additional therapeutic intervention may be warranted. Because MRD can be detected before clinical or radiological evidence of relapse emerges, it provides an early indication of residual disease activity.

What Is Precision Medicine?

Precision medicine involves tailoring treatments to the specific biological characteristics of an individual patient. Instead of using one standard treatment for everyone, clinicians examine DNA changes, biomarkers and other features to understand what is driving the disease. In cancer, identifying the mutations present in a tumor helps determine which therapies are most likely to be effective. Other factors like the Mismatch Repair system (MMR) functionality, Microsatellite High determination, can help choose the right medication. Precision medicine improves treatment outcomes and reduces exposure to therapies that may not work for a given patient.

What Are Companion Diagnostics?

Companion diagnostics are medical tests used alongside specific treatments to determine whether a patient is likely to benefit from them. These tests identify markers or mutations that predict how well a therapy will work. If a tumor carries a mutation targeted by a particular medicine, the test confirms that the treatment is suitable. If not, another option may be chosen. Companion diagnostics ensure that patients receive the therapies most likely to help them.

What Is Tumor DNA?

Tumor DNA refers to genetic material that originates from cancer cells. As cancer cells grow and break apart, fragments of their DNA can enter the bloodstream. This circulating tumor DNA reflects the mutations present in the tumor. By analyzing tumor DNA from blood or tissue, clinicians can identify mutations, track how the cancer is changing and monitor treatment effects. Tumor DNA provides a detailed molecular picture of the disease.

Sample Types and Laboratory Materials

What is FFPE Tissue?

FFPE stands for Formalin Fixed, Paraffin Embedded. It is a standard way to preserve tissue taken during a biopsy or surgery so that it can be examined later. First, the tissue is placed in formalin to prevent decay. It is then embedded in a block of paraffin wax, which makes it stable and easy to cut into very thin slices. FFPE allows pathologists to study tissue under a microscope and enables molecular tests on DNA and RNA. The process can fragment genetic material, but with appropriate methods, reliable analysis is still possible even years after collection.

What is Circulating Tumor DNA (ctDNA)?

Circulating tumor DNA consists of small fragments (<150 bp) of DNA released by cancer cells into the bloodstream. Because these fragments carry the same mutations as the tumor, a blood sample can be used to study the cancer’s genetic profile. This approach, often called a liquid biopsy, helps with early detection, treatment selection, and monitoring of response or relapse. ctDNA can reveal changes in the tumor over time, supporting more timely clinical decisions without requiring repeated tissue biopsies.

What are Circulating Tumor Cells (CTCs)?

Circulating Tumor Cells are intact cancer cells that have entered the bloodstream from a primary tumor. They are less common than ctDNA fragments but provide complementary information. Because CTCs are whole cells, laboratories can examine their appearance, genetics, and behavior. This can help characterize the disease and explore how it might spread. Analyses of CTCs are used in research and, in some settings, to support prognosis and treatment planning.

What Determines DNA Quality in Diagnostic Samples?

DNA quality depends on how a sample is collected, stabilized, stored, and extracted. Delays between collection and processing, exposure to heat, or unsuitable storage can degrade DNA. Preservation methods influence integrity; FFPE is robust for storage but can fragment nucleic acids, whereas fresh or frozen samples often retain longer DNA strands if handled correctly. Extraction methods must minimize damage and contamination. High‑quality DNA increases the likelihood of clear, reproducible results and reduces the chance of inconclusive tests.

Diagnostic Testing Technologies

What is Allele‑Specific PCR?

Allele‑Specific PCR is a targeted amplification method designed to distinguish between nearly identical DNA sequences that differ by as little as a single nucleotide. Primers are engineered to match either the reference sequence or a specific variant. When the primer matches perfectly, the reaction proceeds and the target is amplified; when it does not, amplification is suppressed. This approach is useful for detecting known mutations in cancer and inherited conditions and can be applied at low variant frequencies with careful optimization and control.

What is Digital PCR (dPCR)?

Digital PCR partitions a sample into thousands or more individual micro reactions. Each partition is assessed as positive or negative for the target sequence after PCR amplification. By counting positives and applying Poisson statistics, dPCR provides absolute quantification without standard curves and offers high sensitivity for rare variants. This makes it well suited for applications such as minimal residual disease monitoring, detection of low‑level mutations, and precise copy number analysis.

What is Next‑Generation Sequencing (NGS)?

Next‑Generation Sequencing reads millions of DNA fragments in parallel, producing a comprehensive view of genetic changes across many genes or entire genomes. Compared with single‑target assays, NGS can identify multiple mutations, insertions or deletions, copy number changes, and some structural variants in one experiment. It is widely used in oncology, inherited disease testing, and research to guide diagnosis and treatment selection and to understand how diseases evolve over time.

What are Orthogonal Methods in Diagnostics?

Orthogonal methods use different technologies to confirm the same result. For example, a mutation detected by PCR may be validated by NGS or digital PCR. Because each technology has distinct principles and potential sources of error, agreement between methods increases confidence. Orthogonal confirmation is especially important when results drive major clinical decisions or when findings are unexpected, borderline, or technically challenging.

Clinical Implementation and Regulation

What is an In Vitro Diagnostic (IVD) Test?

An In Vitro Diagnostic test is a regulated medical test performed on samples such as blood, tissue, saliva, or urine outside the body, typically in a laboratory. IVD tests must meet defined quality, safety, and performance standards because clinicians use their results to diagnose disease, select therapies, and monitor patients. Regulatory requirements cover design, validation, production, and ongoing quality control to ensure tests are dependable and clinically appropriate.

What is the Difference Between RUO and IVD Tests?

RUO stands for Research Use Only and designates products intended for laboratory research and method development, not for clinical decision‑making. IVD tests are cleared or approved for clinical use and must meet regulatory standards for analytical and clinical performance. In practice, RUO assays support discovery and early development, whereas IVD assays are used in patient care to inform diagnosis, prognosis, and therapy selection.